{
  "market_name": "Medical Marijuana Market",
  "unit": "Billion",
  "cagr": 9.3,
  "value_2024": 6.3,
  "value_2033": 14.03,
  "REGIONAL_RANKING": {
    "first": "North America",
    "second": "Europe",
    "third": "Asia Pacific"
  },
  "EUROPE_COUNTRY_CLASSIFICATION": {
    "Germany": "dominant",
    "United Kingdom": "fastest_growing",
    "France": "emerging"
  },
  "SEGMENTS": {
    "Formulation": [
      "Oils",
      "Tinctures",
      "Edibles",
      "Topicals"
    ],
    "Cannabinoid Composition": [
      "THC-dominant",
      "CBD-dominant",
      "Balanced THC"
    ],
    "Application": [
      "Chronic Pain",
      "Mental Health Disorders",
      "Neurological Disorders",
      "Cancer"
    ],
    "Distribution Channel": [
      "Pharmacies",
      "Online Stores",
      "Dispensaries"
    ],
    "End Use": [
      "Medical Institutions",
      "Homecare Settings",
      "Research Institutions"
    ]
  }
}